• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42045040-080
Device Problems Difficult to Remove (1528); Material Separation (1562); Difficult or Delayed Activation (2577); Difficult to Advance (2920)
Patient Problems Obstruction/Occlusion (2422); Foreign Body In Patient (2687)
Event Date 08/15/2023
Event Type  Injury  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The reported patient effect of occlusion is listed in the supera peripheral stent system instructions for use as a potential adverse event associated to the use of the device.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the heavily tortuous anatomy resulting in the reported difficult to advance.During deployment the tip/nose cone inadvertently got caught on the end of the stent resulting in the reported difficult/delayed activation/deployment and the reported difficult to remove.Interaction/manipulation of the compromised device ultimately resulted in the reported tip material separation.The reported difficulties possibly caused/contributed to the reported patient effects; however, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The treatment appears to be related to the operational context of the procedure.As reported, the tip was left floating in healthy artery.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was to treat a lesion in the superficial femoral artery (sfa) distal to a bypass in the left leg with heavy tortuosity.Atherectomy was not used.Pre-dilatation was performed on the distal anastomosis that was tortuous with a 5mm balloon.No visible waisting was noted during the pre-dilatation.The 4.5x40mm supera self-expanding stent system (sess) crossed the anastomosis and the stent deployed normally but narrowed at the anastomosis trapping the catheter tip on the distal side of the narrowing.The rest of the supera stent was continued to be deployed until there was a few millimeters left to deploy and the catheter moved/jumped forward causing the last few millimeters to retract.The thumb slide was slid back and the locks were locked to remove the catheter but the tip snapped from the catheter distal to the narrowing as it was pulled back.There were no issues with the deployment mechanism.There was minimal resistance during advancement and removal.The delivery system was removed under fluoroscopy.Minimal force was also applied and the nose cone detached without much pulling.The delivery system caught the end of the stent enfolding it proximally and the nose cone getting caught.An unspecified catheter managed to cross the deployed supera which was used to push the tip into the posterior tibial artery.The tip was left floating in healthy artery and occluded it.There was no additional treatment performed.Final angiograms showed flow through the supera stent and fast flow to the foot.The left groin was closed with a vascular closure system.There was no adverse patient sequelae and there was no reported clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17683600
MDR Text Key322642587
Report Number2024168-2023-09598
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number42045040-080
Device Lot Number2121361
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6F 11CM INTRODUCER SHEATH; BOSTON V18 0.018" GUIDEWIRE.
Patient Outcome(s) Disability; Required Intervention;
Patient Age72 YR
Patient SexMale
Patient Weight75 KG
-
-